Bloomfield Hills, MI, United States of America

Lavie Golenberg

USPTO Granted Patents = 8 

Average Co-Inventor Count = 4.1

ph-index = 2

Forward Citations = 8(Granted Patents)


Location History:

  • Singapore, SG (2023)
  • Sherman Oaks, CA (US) (2023)
  • Bloomfield Hills, MI (US) (2023 - 2024)

Company Filing History:


Years Active: 2023-2025

Loading Chart...
8 patents (USPTO):Explore Patents

Title: Innovations in Diabetes Therapy: The Story of Inventor Lavie Golenberg

Introduction

Lavie Golenberg, an accomplished inventor based in Bloomfield Hills, MI, has made significant contributions to the field of diabetes management. With a portfolio of eight patents, Golenberg has developed groundbreaking technologies aimed at improving the delivery of insulin therapy, enhancing patient care, and integrating modern technology into diabetes treatment.

Latest Patents

One of Golenberg's most notable patents involves a predictive system for delivering or guiding therapy for diabetes. This innovative system employs processors that respond to predictions of meal events, facilitating the timely delivery of insulin doses. It ensures that patients receive partial doses before meals and remaining doses during meal events, based on specific movement characteristics of the patient's arm.

Additionally, Golenberg's recent patent addresses synergistic features related to a medication delivery system and a meal transaction application. This initiative enables the utilization of data from food delivery applications to assist in diet and calorie logging while also optimizing the administration of therapy through medication delivery systems like insulin infusion pumps.

Career Highlights

Lavie Golenberg is currently associated with Medtronic MiniMed, Inc., a company renowned for its innovations in diabetes care and technology. His work at Medtronic has positioned him at the forefront of developing solutions that integrate technology and patient management, addressing the complexities of diabetes therapy.

Collaborations

Throughout his career, Golenberg has collaborated with esteemed colleagues, including Louis J. Lintereur and Patrick E. Weydt. These professional partnerships highlight his commitment to advancing diabetes care through shared knowledge and expertise in the medical device industry.

Conclusion

Lavie Golenberg's contributions as an inventor have significantly advanced the technology surrounding diabetes management. His latest patents not only showcase his innovative thinking but also his dedication to improving the lives of those affected by diabetes. As the landscape of medical technology continues to evolve, Golenberg’s work will undoubtedly play a crucial role in shaping future therapies and tools for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…